ANIONICALLY MODIFIED N-SULFONIC POLYALLYLAMINE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE N-SULFONIC POLYALLYLAMINE DERIVATIVE AS THE ACTIVE SUBSTANCE AND USE OF SAID DERIVATE FOR THE PRODUCTION OF A MEDICINE

摘要

An N-sulfonic polyallylamine derivative (NSPAH) with Formula 1 wherein R is -SO3- or -H, and n is an integer from 150 to 15000, and at least one R is -SO3-. An application of the NSPAH as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus. A pharmaceutical composition comprising the NSPAH as an active substance and the application thereof.